Report Detail

Other Global Photodynamic Therapy Drugs (PTD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4614475
  • |
  • 02 September, 2024
  • |
  • Global
  • |
  • 109 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.
According to our (Global Info Research) latest study, the global Photodynamic Therapy Drugs (PTD) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Photodynamic Therapy Drugs (PTD) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Photodynamic Therapy Drugs (PTD) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Photodynamic Therapy Drugs (PTD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Photodynamic Therapy Drugs (PTD) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Photodynamic Therapy Drugs (PTD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Photodynamic Therapy Drugs (PTD) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Aminolevulinic Acid
Hemoporfin
Sinoporphyrin Sodium
Others
Market segment by Application
Pancreatic Cancer
Esophageal Cancer
Skin Cancer
Lung Cancer
Others
Market segment by players, this report covers
DUSA Pharmaceuticals
Soligenix
ORALIA
Theralase
Quest Pharmatech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Guangsheng Pharmaceutical
APExBIO Technology
Thermo Fisher
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Photodynamic Therapy Drugs (PTD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Photodynamic Therapy Drugs (PTD), with revenue, gross margin, and global market share of Photodynamic Therapy Drugs (PTD) from 2019 to 2024.
Chapter 3, the Photodynamic Therapy Drugs (PTD) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Photodynamic Therapy Drugs (PTD) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Photodynamic Therapy Drugs (PTD).
Chapter 13, to describe Photodynamic Therapy Drugs (PTD) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Photodynamic Therapy Drugs (PTD) by Type
    • 1.3.1 Overview: Global Photodynamic Therapy Drugs (PTD) Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type in 2023
    • 1.3.3 Aminolevulinic Acid
    • 1.3.4 Hemoporfin
    • 1.3.5 Sinoporphyrin Sodium
    • 1.3.6 Others
  • 1.4 Global Photodynamic Therapy Drugs (PTD) Market by Application
    • 1.4.1 Overview: Global Photodynamic Therapy Drugs (PTD) Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pancreatic Cancer
    • 1.4.3 Esophageal Cancer
    • 1.4.4 Skin Cancer
    • 1.4.5 Lung Cancer
    • 1.4.6 Others
  • 1.5 Global Photodynamic Therapy Drugs (PTD) Market Size & Forecast
  • 1.6 Global Photodynamic Therapy Drugs (PTD) Market Size and Forecast by Region
    • 1.6.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Photodynamic Therapy Drugs (PTD) Market Size by Region, (2019-2030)
    • 1.6.3 North America Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
    • 1.6.6 South America Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 DUSA Pharmaceuticals
    • 2.1.1 DUSA Pharmaceuticals Details
    • 2.1.2 DUSA Pharmaceuticals Major Business
    • 2.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.1.4 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 DUSA Pharmaceuticals Recent Developments and Future Plans
  • 2.2 Soligenix
    • 2.2.1 Soligenix Details
    • 2.2.2 Soligenix Major Business
    • 2.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.2.4 Soligenix Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Soligenix Recent Developments and Future Plans
  • 2.3 ORALIA
    • 2.3.1 ORALIA Details
    • 2.3.2 ORALIA Major Business
    • 2.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.3.4 ORALIA Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 ORALIA Recent Developments and Future Plans
  • 2.4 Theralase
    • 2.4.1 Theralase Details
    • 2.4.2 Theralase Major Business
    • 2.4.3 Theralase Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.4.4 Theralase Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Theralase Recent Developments and Future Plans
  • 2.5 Quest Pharmatech
    • 2.5.1 Quest Pharmatech Details
    • 2.5.2 Quest Pharmatech Major Business
    • 2.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.5.4 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Quest Pharmatech Recent Developments and Future Plans
  • 2.6 Biofrontera
    • 2.6.1 Biofrontera Details
    • 2.6.2 Biofrontera Major Business
    • 2.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.6.4 Biofrontera Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Biofrontera Recent Developments and Future Plans
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.7.4 Merck Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Merck Recent Developments and Future Plans
  • 2.8 QIYUE BIOLOGY
    • 2.8.1 QIYUE BIOLOGY Details
    • 2.8.2 QIYUE BIOLOGY Major Business
    • 2.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.8.4 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 QIYUE BIOLOGY Recent Developments and Future Plans
  • 2.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
    • 2.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Details
    • 2.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Major Business
    • 2.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments and Future Plans
  • 2.10 Shanghai Guangsheng Pharmaceutical
    • 2.10.1 Shanghai Guangsheng Pharmaceutical Details
    • 2.10.2 Shanghai Guangsheng Pharmaceutical Major Business
    • 2.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.10.4 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Shanghai Guangsheng Pharmaceutical Recent Developments and Future Plans
  • 2.11 APExBIO Technology
    • 2.11.1 APExBIO Technology Details
    • 2.11.2 APExBIO Technology Major Business
    • 2.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.11.4 APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 APExBIO Technology Recent Developments and Future Plans
  • 2.12 Thermo Fisher
    • 2.12.1 Thermo Fisher Details
    • 2.12.2 Thermo Fisher Major Business
    • 2.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Product and Solutions
    • 2.12.4 Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Thermo Fisher Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Photodynamic Therapy Drugs (PTD) Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Photodynamic Therapy Drugs (PTD) by Company Revenue
    • 3.2.2 Top 3 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
    • 3.2.3 Top 6 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
  • 3.3 Photodynamic Therapy Drugs (PTD) Market: Overall Company Footprint Analysis
    • 3.3.1 Photodynamic Therapy Drugs (PTD) Market: Region Footprint
    • 3.3.2 Photodynamic Therapy Drugs (PTD) Market: Company Product Type Footprint
    • 3.3.3 Photodynamic Therapy Drugs (PTD) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Photodynamic Therapy Drugs (PTD) Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Photodynamic Therapy Drugs (PTD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Photodynamic Therapy Drugs (PTD) Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
  • 6.2 North America Photodynamic Therapy Drugs (PTD) Market Size by Application (2019-2030)
  • 6.3 North America Photodynamic Therapy Drugs (PTD) Market Size by Country
    • 6.3.1 North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
    • 6.3.2 United States Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
  • 7.2 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
  • 7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country
    • 7.3.1 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 7.3.3 France Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region
    • 8.3.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2030)
    • 8.3.2 China Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 8.3.5 India Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
  • 9.2 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
  • 9.3 South America Photodynamic Therapy Drugs (PTD) Market Size by Country
    • 9.3.1 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country
    • 10.3.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Photodynamic Therapy Drugs (PTD) Market Drivers
  • 11.2 Photodynamic Therapy Drugs (PTD) Market Restraints
  • 11.3 Photodynamic Therapy Drugs (PTD) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Photodynamic Therapy Drugs (PTD) Industry Chain
  • 12.2 Photodynamic Therapy Drugs (PTD) Upstream Analysis
  • 12.3 Photodynamic Therapy Drugs (PTD) Midstream Analysis
  • 12.4 Photodynamic Therapy Drugs (PTD) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Photodynamic Therapy Drugs (PTD). Industry analysis & Market Report on Photodynamic Therapy Drugs (PTD) is a syndicated market report, published as Global Photodynamic Therapy Drugs (PTD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Photodynamic Therapy Drugs (PTD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,641.32
    3,961.98
    5,282.64
    3,128.52
    4,692.78
    6,257.04
    492,802.80
    739,204.20
    985,605.60
    291,728.40
    437,592.60
    583,456.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report